Screener
Carlsmed, Inc. CARL Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $18.94M+56.7% | $16.12M+58.2% | $15.17M+61.2% | $13.07M+98.4% | $12.08M+98.7% | ||
| $4.4M+36.8% | $3.69M+44.6% | $3.56M+49.2% | $3.15M+75.6% | $3.21M+112% | ||
| $14.54M+64.0% | $12.43M+62.7% | $11.61M+65.3% | $9.93M+107% | $8.87M+94.4% | ||
| 76.8%+3.4pp | 77.1%+2.2pp | 76.5%+1.9pp | 75.9%+3.1pp | 73.4%-1.6pp | ||
| $6.04M+45.2% | $5.18M+64.4% | $5.26M+74.6% | $4.45M+10.2% | $4.16M+4.1% | ||
| $11.92M+51.5% | $10.3M+52.8% | $10.81M+69.4% | $9.61M+45.1% | $7.87M+61.5% | ||
| $7.62M+128% | $6.23M+79.6% | $4.85M+109% | $4.91M+156% | $3.34M+66.3% | ||
| $25.58M+66.4% | $21.7M+62.5% | $20.93M+78.5% | $18.96M+50.8% | $15.37M+41.3% | ||
| -$11.04M-69.7% | -$9.28M-62.2% | -$9.32M-98.4% | -$9.04M-16.2% | -$6.5M-2.9% | ||
| -58.3%-4.5pp | -57.6%-1.4pp | -61.4%-11.5pp | -69.1%+48.9pp | -53.8%+50.1pp | ||
| $313K-13.8% | $311K-12.9% | $330K-12.7% | $380K-5.5% | $363K+11.7% | ||
| $526K+299% | $580K+5,900% | $705K+3,165% | $509K+1,514% | -$264K-729% | ||
| -$10.51M-55.3% | -$8.7M-51.8% | -$8.61M-82.5% | -$8.53M-9.1% | -$6.77M-7.8% | ||
| -55.5%+0.5pp | -54%+2.3pp | -56.8%-6.6pp | -65.2%+53.3pp | -56%+47.2pp | ||
| -$0.39+73.5% | -$0.32+78.2% | —— | -$0.40+80.6% | -$1.47+5.2% | ||
| -$10.91M-69.3% | -$9.18M-61.6% | -$9.22M-97.9% | -$8.95M-15.6% | -$6.44M— | ||
| -57.6%-4.3pp | -56.9%-1.2pp | -60.8%-11.3pp | -68.5%+49.0pp | -53.3%— | ||
| -$11.04M-69.7% | -$9.28M-62.2% | -$9.32M-98.4% | -$9.04M-16.2% | -$6.5M-2.9% |
FAQ
- What is Carlsmed, Inc.'s revenue?
- Carlsmed, Inc. (CARL) generated $63.3M in revenue over the trailing twelve months, up 65.4% year over year.
- Is Carlsmed, Inc. profitable?
- Carlsmed, Inc. is not currently profitable: it reported a net loss of $36.3M over the trailing twelve months, a -57.4% net margin.
- What are Carlsmed, Inc.'s profit margins?
- Gross margin is 76.6% and operating margin is -61.1%, with a -57.4% net margin.
- What is Carlsmed, Inc.'s earnings per share?
- Carlsmed, Inc.'s diluted EPS over the trailing twelve months is $-2.58.
- Where does Carlsmed, Inc.'s income statement data come from?
- Every line is extracted from Carlsmed, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
